LifeVantage Co. (NASDAQ:LFVN – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 193,700 shares, a growth of 52.2% from the August 31st total of 127,300 shares. Based on an average daily trading volume, of 79,500 shares, the short-interest ratio is presently 2.4 days. Currently, 2.0% of the shares of the company are short sold.
LifeVantage Stock Performance
NASDAQ:LFVN traded up $0.25 during mid-day trading on Friday, reaching $13.44. 52,161 shares of the company’s stock were exchanged, compared to its average volume of 54,381. LifeVantage has a one year low of $4.20 and a one year high of $13.71. The business’s fifty day simple moving average is $8.54 and its two-hundred day simple moving average is $7.32. The firm has a market capitalization of $170.70 million, a PE ratio of 47.11 and a beta of 0.82.
LifeVantage (NASDAQ:LFVN – Get Free Report) last announced its earnings results on Wednesday, August 28th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.07). The business had revenue of $48.93 million for the quarter. LifeVantage had a return on equity of 27.85% and a net margin of 1.47%.
LifeVantage Dividend Announcement
Institutional Trading of LifeVantage
Several large investors have recently modified their holdings of the stock. Empowered Funds LLC boosted its position in shares of LifeVantage by 8.1% during the 1st quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock worth $461,000 after acquiring an additional 5,742 shares in the last quarter. Vanguard Group Inc. lifted its stake in LifeVantage by 2.8% during the first quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock worth $2,874,000 after purchasing an additional 12,809 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in shares of LifeVantage by 2.8% in the 1st quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after purchasing an additional 6,121 shares in the last quarter. Hillsdale Investment Management Inc. bought a new position in shares of LifeVantage in the 1st quarter valued at $76,000. Finally, Hantz Financial Services Inc. acquired a new position in shares of LifeVantage during the 2nd quarter worth $91,000. 35.32% of the stock is owned by institutional investors and hedge funds.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Further Reading
- Five stocks we like better than LifeVantage
- What does consumer price index measure?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Which Wall Street Analysts are the Most Accurate?
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
- What is the S&P 500 and How It is Distinct from Other Indexes
- What Intuitive Machines’ Big NASA Contract Means for Investors
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.